Raphin1 acetate
Modify Date: 2024-01-04 00:19:51
Raphin1 acetate structure
|
Common Name | Raphin1 acetate | ||
|---|---|---|---|---|
| CAS Number | 2242616-04-0 | Molecular Weight | 291.13 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C10H12Cl2N4O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Raphin1 acetateRaphin1 acetate is an orally bioavailable, selective inhibitor of the regulatory phosphatase PPP1R15B (R15B). Raphin1 acetate binds strongly to the R15B-PP1c holophosphatase (Kd=33 nM), and shows ~30-fold selective in binding R15B-PP1c over R15A-PP1c. Raphin1 acetate crosses the blood-brain barrier, and reduces organismal and molecular deficits in a mouse model of a protein misfolding disease[1]. |
| Name | Raphin1 acetate |
|---|---|
| Synonym | More Synonyms |
| Description | Raphin1 acetate is an orally bioavailable, selective inhibitor of the regulatory phosphatase PPP1R15B (R15B). Raphin1 acetate binds strongly to the R15B-PP1c holophosphatase (Kd=33 nM), and shows ~30-fold selective in binding R15B-PP1c over R15A-PP1c. Raphin1 acetate crosses the blood-brain barrier, and reduces organismal and molecular deficits in a mouse model of a protein misfolding disease[1]. |
|---|---|
| Related Catalog | |
| Target |
Kd: 33 nM (R15B-PP1c holophosphatase)[1] |
| In Vitro | Raphin1 acetate causes a rapid and transient accumulation of its phosphorylated substrate, resulting in a transient attenuation of protein synthesis[1]. Raphin1 acetate inhibits the recombinant R15B-PP1c holoenzyme, but not the closely related R15A-PP1c, by interfering with substrate recruitment[1]. |
| In Vivo | Raphin1 acetate improves weight of HD82Q mice treated from 4 to ∼10 weeks of age with 2 mg/kg of Raphin1 once a day by oral gavage. Raphin1 acetate also decreases SDS-insoluble huntingtin assemblies and nuclear inclusions in the cortex of HD82Q mice[1]. |
| References |
| Molecular Formula | C10H12Cl2N4O2 |
|---|---|
| Molecular Weight | 291.13 |
| MFCD32201062 |